Progress and promises of epigenetic drugs and epigenetic diets in cancer prevention and therapy: A clinical update.

Mondal, Priya; Natesh, Jagadish; Penta, Dhanamjai; Meeran, Syed Musthapa

Mondal, Priya; Natesh, Jagadish; Penta, Dhanamjai; Meeran, Syed Musthapa.

Afiliación

Mondal P; Department of Biochemistry, CSIR-Central Food Technological Research Institute, Mysore, 570020, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
Natesh J; Department of Biochemistry, CSIR-Central Food Technological Research Institute, Mysore, 570020, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
Penta D; Department of Biochemistry, CSIR-Central Food Technological Research Institute, Mysore, 570020, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
Meeran SM; Department of Biochemistry, CSIR-Central Food Technological Research Institute, Mysore, 570020, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India. Electronic address: s.musthapa@cftri.res.in.

Semin Cancer Biol ; 83: 503-522, 2022 08.

Article en En | MEDLINE | ID: mdl-33309850

Asunto(s)

Epigenómica; Neoplasias; Metilación de ADN; Dieta; Epigénesis Genética; Humanos; Neoplasias/tratamiento farmacológico; Neoplasias/genética; Neoplasias/prevención & control

Palabras clave

Cancer epigenetics; Clinical trials; Dietary bioactives; Epigenetic diets; Epigenetic drugs

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Epigenómica / Neoplasias Límite: Humans Idioma: En Revista: Semin Cancer Biol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: India

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google